簇集蛋白(CLU)多克隆抗體
Polyclonal Antibody to Clusterin (CLU)
CLU; TRPM2; KUB1; CLI; APOJ; SGP2; AAG4; APO-J; SP-40; Apolipoprotein J; Complement Lysis Inhibitor; 40,Sulfated Glycoprotein 2; Testosterone-Repressed Prostate Message 2
- 編號UPAB180Hu01
 - 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
 - 來源多抗制備
 - 宿主兔
 - 效價-
 - Ig類型 IgG
 - 純化方式抗原特異性親和純化
 - 標記物無標記物
 - 免疫原 RPB180Hu01-簇集蛋白(CLU)重組蛋白
 - 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
 - 性狀液體
 - 濃度0.5mg/mL
 - 且適物種Mus musculus (Mouse,小鼠)
 - 應用WB; IHC
如果抗體需用于流式細胞術,請參見流式抗體。 - 下載 英文說明書 中文說明書
 - 規(guī)格 20μl100μl 200μl 1ml 10ml
 - 價格 ¥ 211 ¥ 491 ¥ 702 ¥ 1755 ¥ 7020
 - 欲了解實際交易價格和更多情況,請與當?shù)亟涗N商聯(lián)系!
 
特異性
該抗體是針對CLU的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CLU。
用法
            Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.        
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) | 
| URPB180Hu02 | 簇集蛋白(CLU)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPB180Hu01 | 簇集蛋白(CLU)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UPAB180Hu01 | 簇集蛋白(CLU)多克隆抗體 | WB; IHC | 
| ULAB180Hu81 | 簇集蛋白(CLU)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. | 
| ULAB180Hu71 | 簇集蛋白(CLU)多克隆抗體(生物素標記) | WB; IHC; ICC. | 
| UMAB180Hu23 | 簇集蛋白(CLU)單克隆抗體 | WB; ICC/IF | 
| UMAB180Hu22 | 簇集蛋白(CLU)單克隆抗體 | WB | 
| UMAB180Hu21 | 簇集蛋白(CLU)單克隆抗體 | ICC/IF | 
| UFAB180Hu02 | 抗簇集蛋白(CLU)單克隆抗體 | FCM | 
| USEB180Hu | 簇集蛋白(CLU)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| ULMB180Hu | 簇集蛋白(CLU)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
| UKSB180Hu01 | 簇集蛋白(CLU)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". | 
參考文獻
| 雜志 | 參考文獻 | 
| Endocrinology | Deficiency of Clusterin Exacerbates High-Fat Diet-Induced Insulin Resistance in Male Mice [Pubmed: 24684302] | 
| J Mol Neurosci. | Time-Dependent Decrease of Clusterin as a Potential Cerebrospinal Fluid Biomarker for Drug-Resistant Epilepsy. [Pubmed: 24488574] | 
| PLOS ONE | Serum Amyloid A and Clusterin as Potential Predictive Biomarkers for Severe Hand, Foot and Mouth Disease by 2D-DIGE Proteomics Analysis [Pubmed:25268271] | 
| journal of immunological methods | Proteomic analysis of human plasma and peripheral blood mononuclear cells in Systemic Lupus Erythematosus patients. [pubmed:28390925] | 
| Journal?of?Alzheimer's?Disease | Proteomics?Analysis?of?Blood?Serums?from?Alzheimer's?Disease?Patients?Using?iTRAQ?LabelingTechnology. [pubmed:27911324] | 
| Biochimica Et Biophysica Acta | Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells [pubmed:28941799] | 
| World Neurosurgery | Clusterin, a New Cerebrospinal Fluid Biomarker in Severe Subarachnoid Hemorrhage: A Pilot Study [pubmed:28803177] | 
| BMC Cancer | Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis [Pubmed:29386009] | 
| Diabetes/metabolism research and reviews | High serum clusterin levels are correlated with premature coronary artery disease in a Chinese population [Pubmed: 30659732] | 
| Cancer Cell Int | Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer [33602229] | 

                    
                    
                            